Prof. Ruth Roberts Receives International Award for Drug and Chemical Safety Work
Professor Ruth Roberts. Credit: ApconiX
Professor Ruth Roberts – co-founder and director of nonclinical safety company, ApconiX based at Alderley Park, Cheshire – is the first non-US-based scientist to receive a prestigious international award for professionals specialising in drug and chemical safety.
She is only the tenth person to receive the US-based Society of Toxicology (SOT) Founders Award, presented for “outstanding leadership in fostering the role of toxicological sciences in safety decision making”.
Professor Roberts joins more than two-dozen other professionals acknowledged by the Society of Toxicology in its latest awards for “the furtherance of the science of toxicology”.
The SOT, a professional and scholarly organization of more than 8,200 scientists, has represented toxicology practitioners and recognised achievements in the field for more than half a century. Toxicologists assess the effects of chemicals and other biological agents on human, animal, and environmental health and endeavour to understand how to prevent and ameliorate adverse effects. From the safety of medicines to the impact of environmental pollutants, toxicologists continually strive to create a safer, healthier world.
William Slikker Jr of the US Food and Drug Administration National Centre for Toxicological Research and past SOT President said: “Ruth Roberts’ vision of integrated research and drug safety programmes covering several modalities and methodological approaches have served her well. Her strategies have improvement of human health as their goal and rely on the synthesis of basic research and clinical application to achieve a new level of understanding.”
Professor Roberts, who co-founded ApconiX in 2015 – recently awarded Start-up of the Year by North of England biomedical and life sciences organisation, BioNow – is chair and director of drug discovery at the University of Birmingham in the UK. Previously, she worked in senior roles in regulatory safety, drug discovery and development and scientific strategy for companies such as AstraZeneca, ICI, Syngenta, and Aventis.
A graduate from the University of Manchester, she received her PhD in 1987 and received the SOT Achievement Award in 2002 for her contributions to the molecular understanding of toxicity along with the EUROTOX Bo Holmstedt Award in 2008 for scientific excellence in the area of drug and chemical safety.
The 2018 SOT Award recipients will be honoured formally at an awards ceremony during the Society’s 57th Annual Meeting and ToxExpo in San Antonio, Texas, March 11–15, 2018.
This article has been republished from materials provided by ApconiX. Note: material may have been edited for length and content. For further information, please contact the cited source.
Researchers Uncover Muscle Growth Inhibitor Activation Mechanism Aiding ALS Treatment EffortsNews
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for limiting muscle, is activated.READ MORE
New Research Could Significantly Accelerate Drug DiscoveryNews
Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.READ MORE
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.